Patients with a severe form of ventricular arrhythmia who may be referred for catheter ablation are often first tested for coronary artery disease (CAD) or ischemia. But such testing seldom makes a ...
Patients with structural heart disease and monomorphic ventricular tachycardia (VT), irrespective of its etiology, can benefit when early first-line catheter ablation is added before implanting an ...
April 30, 2004 — An infusion of n-3 polyunsaturated fatty acids (PUFA) had immediate inhibitory effects on sustained ventricular tachycardia, according to the results of a pilot study published in the ...
Proceeds Expected to Fund Ongoing Development and Submission Activities to Support FDA Evaluation of Company’s First and Next Generation Proprietary Ultralow Cryoablation Technologies The Company ...
A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results